glp-1 weight-loss drugs World Health Organization issues first-ever guidelines for use of weight loss medications 6 Things to Know About

(2009) Improved treatment satisfaction and weight-related quality of life with exenatide once weekly or twice daily

Patients with diabetes already face elevated pancreatitis risk due to obesity, hypertriglyceridemia, and metabolic syndromeconditions common among those prescribed GLP-1 medications

Adverse Effects The most common adverse effects are upper respiratory tract infection, nasopharyngitis, and headache

M.AndradeC

DPP4is (e.g., sitagliptin, saxagliptin, vildagliptin, linagliptin, alogliptin, and teneligliptin) are a group of oral medications designed to manage T2DM by prolonging the activity of incretin hormones (GLP1 and GIP)

Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus